Résultats de la recherche - 5 results
Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017
interval (CI): 26.8-31.1%) and 7.1% (95% CI: 6.1-8.3%), respectively. The objective of this report is to present the results of the second ECDC PPS conducted in 2017 in Belgian acute care hospitals. Methods ...
Epidemiology of Clostridium difficile infection in Belgium: Report 2016
Differences in surveillance methods of CDI reported in European countries make comparisons difficult. Health Topics: Résistance aux antimicrobiens (AMR) Antimicrobiële resistentie (AMR) Antimicrobial ...
Trends in mortality and morbidity related to Clostridium difficile infections, Belgium 1998-2007
1998-2007, to assess the epidemiology of CDI in Belgium. Methods We selected available data from: (1) mortality registries from Brussels, Flanders and Wallonia regions, (1998-2007)-records with ICD-10 code for ...
In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals
Staphylococcus aureus method methods Microbial Sensitivity Tests microbiology Minocycline Molecular Epidemiology MRSA Multilocus Sequence Typing multiplex PCR national National Survey nosocomial Oxacillin Patient ...
ST131 fimH22 Escherichia coli isolate with a blaCMY-2/IncI1/ST12 plasmid obtained from a patient with bloodstream infection: highly similar to E. coli isolates of broiler origin.
the genome of an ST131 CMY-2-producing Escherichia coli isolate from a Danish patient with other ST131 CMY-2-producing E. coli isolates of both human and animal origin. METHODS: In 2016, an ST131 ...